Background: StarlinkTM, a variety of corn genetically engineered to contain the insecticidal protein Cry9c, had not been approved for human consumption because it possessed some characteristics associated with allergenic proteins. However, in the fall of 2000 cry9c DNA was detected in several corn-containing products, suggesting that Starlink corn had entered the human food supply. Subsequently, consumers, following consumption of corn products, reported a number of adverse health events, possibly consistent with allergic reaction. Methods: To investigate the possibility of allergic reactions due to Cry9c in these consumers an ELISA test was developed for the purpose of detecting IgE antibodies to Cry9c and blood samples were taken from a total of 18 people who self-reported allergic reactions. Sera collected prior to the 1996 development of Starlink were used as negative controls. Results: None of the adverse event sera were found to be reactive with recombinant Cry9c antigen, based on comparison with normal controls. Although a known human positive control serum containing IgE specific for Cry9c was not available, other controls were incorporated into the ELISA protocol, including the use of sera from subjects allergic to other allergens and their homologous antigens (cat, grass, peanut) to validate the IgE detection reagents. Conclusions: While the results do not support the likely occurrence of allergic reactions to Cry9c, such reactions cannot be ruled out, nor can the possibility that sera might react with unique glycosylated epitopes of Cry9c that may be expressed in the corn plant/seed.

1.
Bucchini L, Goldman LR: Starlink corn: A risk analysis. Environ Health Perspect 2002;110:5–13.
2.
Metcalfe DD, Astwood JD, Townsend R, Sampson HA, Taylor SL, Fuchs RL: Assessment of the allergenic potential of foods derived from genetically engineered crop plants. Crit Rev Food Sci Nutr 1996;36(suppl):S165–S186.
3.
Astwood JD, Fuchs RL: Allergenicity of foods derived from transgenic plants. Monogr Allergy 1996;32:105–120.
4.
Astwood JD, Leach JN, Fuchs RL: Stability of food allergens to digestion in vitro. Nat Biotechnol 1996;14:1269–1273.
5.
Medzihradszky KF, Leffler H, Baldwin MA, Burlingame AL: Protein identification by in-gel digestion, high-performance liquid chromatography, and mass spectrometry: peptide analysis by complementary ionization techniques. J Am Soc Mass Spectrom 2001;12:215–221.
6.
Trucksess NW: Determination of Cry9C protein in corn-based foods by enzyme-linked immunosorbent assay: interlaboratory study. J AOAC Int 2001;84:1891–1901.
7.
Rose NR: Manual of Clinical Laboratory Immunology, ed 4. Washington, ASM Press, 1992.
8.
Morgan JE, Daul CB, Lehrer SB: The relationships among shrimp-specific IgG subclass antibodies and immediate adverse reactions to shrimp challenge. J Allergy Clin Immunol 1990;86(3 pt 1):387–392.
9.
Sampson HA, Burks AW: Mechanisms of food allergy. Annu Rev Nutr 1996;16:161–177.
10.
Ewan PW, Coote D: Evaluation of a capsulated hydrophilic carrier polymer (the ImmunoCAP) for measurement of specific IgE antibodies. Allergy 1990;45:22–29.
11.
Ogura Y, Ogura H, Zushi N, Morita H, Kurashige T: The usefulness and limitations of the radioallergosorbent test in diagnosing food allergy in atopic dermatitis. Arerugi 1993;42:748–756.
12.
Bindslev-Jensen C, Poulsen LK: Some limitations in the use of specific IgE in the diagnosis of food hypersensitivity. Monogr Allergy 1996;32:216–220.
13.
Bernstein IL, Bernstein JA, Miller M, Tierzieva S, Bernstein DI, Lummus Z, Selgrade MK, Doerfler DL, Seligy VL: Immune responses in farm workers after exposure to Bacillus thuringiensis pesticides. Environ Health Perspect 1999;107:575–582.
14.
Crickmore N, Zeigler DR, Feitelson J, Schnepf E, Van Rie J, Lereclus D, Baum J, Dean DH: Revision of the nomenclature for the Bacillus thuringiensis pesticidal crystal proteins. Microbiol Mol Biol Rev 1998;62:807–813.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.